Logo image of ELA

ENVELA CORP (ELA) Stock Fundamental Analysis

USA - NYSEARCA:ELA - US29402E1029 - Common Stock

7.75 USD
0 (0%)
Last: 10/15/2025, 12:08:58 PM
Fundamental Rating

7

Taking everything into account, ELA scores 7 out of 10 in our fundamental rating. ELA was compared to 120 industry peers in the Specialty Retail industry. ELA has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. ELA is not priced too expensively while it is growing strongly. Keep and eye on this one! These ratings could make ELA a good candidate for growth and quality investing.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

ELA had positive earnings in the past year.
In the past year ELA had a positive cash flow from operations.
ELA had positive earnings in each of the past 5 years.
In the past 5 years ELA always reported a positive cash flow from operatings.
ELA Yearly Net Income VS EBIT VS OCF VS FCFELA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M 15M

1.2 Ratios

The Return On Assets of ELA (10.31%) is better than 84.17% of its industry peers.
The Return On Equity of ELA (14.77%) is better than 72.50% of its industry peers.
With a decent Return On Invested Capital value of 11.43%, ELA is doing good in the industry, outperforming 79.17% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for ELA is in line with the industry average of 12.17%.
Industry RankSector Rank
ROA 10.31%
ROE 14.77%
ROIC 11.43%
ROA(3y)13.47%
ROA(5y)14.62%
ROE(3y)21.28%
ROE(5y)27.31%
ROIC(3y)12.62%
ROIC(5y)13.55%
ELA Yearly ROA, ROE, ROICELA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60

1.3 Margins

ELA has a Profit Margin of 4.30%. This is in the better half of the industry: ELA outperforms 74.17% of its industry peers.
ELA's Profit Margin has improved in the last couple of years.
The Operating Margin of ELA (5.18%) is better than 68.33% of its industry peers.
In the last couple of years the Operating Margin of ELA has grown nicely.
Looking at the Gross Margin, with a value of 23.68%, ELA is doing worse than 74.17% of the companies in the same industry.
In the last couple of years the Gross Margin of ELA has grown nicely.
Industry RankSector Rank
OM 5.18%
PM (TTM) 4.3%
GM 23.68%
OM growth 3Y-12.44%
OM growth 5Y2.74%
PM growth 3Y-19.3%
PM growth 5Y2.02%
GM growth 3Y3.52%
GM growth 5Y4.39%
ELA Yearly Profit, Operating, Gross MarginsELA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

9

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ELA is still creating some value.
Compared to 1 year ago, ELA has less shares outstanding
Compared to 5 years ago, ELA has less shares outstanding
The debt/assets ratio for ELA has been reduced compared to a year ago.
ELA Yearly Shares OutstandingELA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
ELA Yearly Total Debt VS Total AssetsELA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

An Altman-Z score of 8.66 indicates that ELA is not in any danger for bankruptcy at the moment.
ELA has a Altman-Z score of 8.66. This is amongst the best in the industry. ELA outperforms 98.33% of its industry peers.
The Debt to FCF ratio of ELA is 1.73, which is an excellent value as it means it would take ELA, only 1.73 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of ELA (1.73) is better than 77.50% of its industry peers.
A Debt/Equity ratio of 0.17 indicates that ELA is not too dependend on debt financing.
ELA has a better Debt to Equity ratio (0.17) than 65.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF 1.73
Altman-Z 8.66
ROIC/WACC1.24
WACC9.25%
ELA Yearly LT Debt VS Equity VS FCFELA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M 50M

2.3 Liquidity

A Current Ratio of 4.58 indicates that ELA has no problem at all paying its short term obligations.
ELA has a better Current ratio (4.58) than 97.50% of its industry peers.
ELA has a Quick Ratio of 2.36. This indicates that ELA is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 2.36, ELA belongs to the best of the industry, outperforming 92.50% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.58
Quick Ratio 2.36
ELA Yearly Current Assets VS Current LiabilitesELA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

8

3. Growth

3.1 Past

ELA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 37.50%, which is quite impressive.
ELA shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 20.12% yearly.
Looking at the last year, ELA shows a very strong growth in Revenue. The Revenue has grown by 25.43%.
ELA shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 17.07% yearly.
EPS 1Y (TTM)37.5%
EPS 3Y-12.25%
EPS 5Y20.12%
EPS Q2Q%83.33%
Revenue 1Y (TTM)25.43%
Revenue growth 3Y8.56%
Revenue growth 5Y17.07%
Sales Q2Q%21.15%

3.2 Future

ELA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 24.07% yearly.
ELA is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.18% yearly.
EPS Next Y44.03%
EPS Next 2Y24.07%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year18.32%
Revenue Next 2Y10.18%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
ELA Yearly Revenue VS EstimatesELA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M 200M
ELA Yearly EPS VS EstimatesELA Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 0.1 0.2 0.3 0.4 0.5

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 23.48, the valuation of ELA can be described as rather expensive.
Compared to the rest of the industry, the Price/Earnings ratio of ELA indicates a somewhat cheap valuation: ELA is cheaper than 68.33% of the companies listed in the same industry.
ELA's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.49.
A Price/Forward Earnings ratio of 20.14 indicates a rather expensive valuation of ELA.
The rest of the industry has a similar Price/Forward Earnings ratio as ELA.
When comparing the Price/Forward Earnings ratio of ELA to the average of the S&P500 Index (22.99), we can say ELA is valued inline with the index average.
Industry RankSector Rank
PE 23.48
Fwd PE 20.14
ELA Price Earnings VS Forward Price EarningsELA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

ELA's Enterprise Value to EBITDA ratio is in line with the industry average.
ELA's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. ELA is cheaper than 65.83% of the companies in the same industry.
Industry RankSector Rank
P/FCF 26.72
EV/EBITDA 15.91
ELA Per share dataELA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

ELA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of ELA may justify a higher PE ratio.
ELA's earnings are expected to grow with 24.07% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.53
PEG (5Y)1.17
EPS Next 2Y24.07%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

ELA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ENVELA CORP

NYSEARCA:ELA (10/15/2025, 12:08:58 PM)

7.75

0 (0%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)08-06 2025-08-06/amc
Earnings (Next)11-05 2025-11-05/amc
Inst Owners14.65%
Inst Owner Change0%
Ins Owners49.48%
Ins Owner Change0.31%
Market Cap201.27M
Analysts80
Price Target10.2 (31.61%)
Short Float %2.97%
Short Ratio3.78
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)54.5%
Min EPS beat(2)41.44%
Max EPS beat(2)67.56%
EPS beat(4)4
Avg EPS beat(4)44.08%
Min EPS beat(4)18.81%
Max EPS beat(4)67.56%
EPS beat(8)6
Avg EPS beat(8)21.46%
EPS beat(12)8
Avg EPS beat(12)27.4%
EPS beat(16)12
Avg EPS beat(16)29.08%
Revenue beat(2)2
Avg Revenue beat(2)9.1%
Min Revenue beat(2)2.14%
Max Revenue beat(2)16.06%
Revenue beat(4)4
Avg Revenue beat(4)14.28%
Min Revenue beat(4)2.14%
Max Revenue beat(4)21.16%
Revenue beat(8)6
Avg Revenue beat(8)5.22%
Revenue beat(12)9
Avg Revenue beat(12)5.09%
Revenue beat(16)12
Avg Revenue beat(16)8.2%
PT rev (1m)0%
PT rev (3m)5.26%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.79%
EPS NY rev (1m)2.89%
EPS NY rev (3m)11.41%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.18%
Revenue NY rev (1m)0%
Revenue NY rev (3m)6.33%
Valuation
Industry RankSector Rank
PE 23.48
Fwd PE 20.14
P/S 1.01
P/FCF 26.72
P/OCF 18.45
P/B 3.48
P/tB 4
EV/EBITDA 15.91
EPS(TTM)0.33
EY4.26%
EPS(NY)0.38
Fwd EY4.97%
FCF(TTM)0.29
FCFY3.74%
OCF(TTM)0.42
OCFY5.42%
SpS7.64
BVpS2.22
TBVpS1.94
PEG (NY)0.53
PEG (5Y)1.17
Profitability
Industry RankSector Rank
ROA 10.31%
ROE 14.77%
ROCE 14.62%
ROIC 11.43%
ROICexc 16.93%
ROICexgc 20.06%
OM 5.18%
PM (TTM) 4.3%
GM 23.68%
FCFM 3.8%
ROA(3y)13.47%
ROA(5y)14.62%
ROE(3y)21.28%
ROE(5y)27.31%
ROIC(3y)12.62%
ROIC(5y)13.55%
ROICexc(3y)17.69%
ROICexc(5y)18.43%
ROICexgc(3y)21.62%
ROICexgc(5y)22.7%
ROCE(3y)16.14%
ROCE(5y)17.45%
ROICexcg growth 3Y-9.57%
ROICexcg growth 5Y-0.97%
ROICexc growth 3Y-7.64%
ROICexc growth 5Y1.09%
OM growth 3Y-12.44%
OM growth 5Y2.74%
PM growth 3Y-19.3%
PM growth 5Y2.02%
GM growth 3Y3.52%
GM growth 5Y4.39%
F-Score7
Asset Turnover2.4
Health
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF 1.73
Debt/EBITDA 0.8
Cap/Depr 192.86%
Cap/Sales 1.7%
Interest Coverage 26.86
Cash Conversion 90.66%
Profit Quality 88.29%
Current Ratio 4.58
Quick Ratio 2.36
Altman-Z 8.66
F-Score7
WACC9.25%
ROIC/WACC1.24
Cap/Depr(3y)141.77%
Cap/Depr(5y)313.83%
Cap/Sales(3y)1.17%
Cap/Sales(5y)2.18%
Profit Quality(3y)69.25%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)37.5%
EPS 3Y-12.25%
EPS 5Y20.12%
EPS Q2Q%83.33%
EPS Next Y44.03%
EPS Next 2Y24.07%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)25.43%
Revenue growth 3Y8.56%
Revenue growth 5Y17.07%
Sales Q2Q%21.15%
Revenue Next Year18.32%
Revenue Next 2Y10.18%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y31.97%
EBIT growth 3Y-4.94%
EBIT growth 5Y20.28%
EBIT Next Year69.06%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y49.57%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y70.33%
OCF growth 3Y53.73%
OCF growth 5YN/A